Taiyen Biotech Co Ltd (1737) — Free Cash Flow Generation Index
Taiyen Biotech Co Ltd (1737) has a Free Cash Flow Generation Index of 0.48x as of December 2025. Free cash flow of NT$92.36 Million represents 0% of operating cash flow (NT$194.08 Million). See working capital to net assets of Taiyen Biotech Co Ltd to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Taiyen Biotech Co Ltd Free Cash Flow Generation Index (2003–2025)
Historical FCF Generation Index trend for Taiyen Biotech Co Ltd across 23 annual periods. Explore Taiyen Biotech Co Ltd (1737) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for Taiyen Biotech Co Ltd (2003–2025)
Year-by-year Free Cash Flow Generation Index for Taiyen Biotech Co Ltd. For the full company profile including market capitalisation, see Taiyen Biotech Co Ltd market cap and net worth.
| Year | FCG Index | Free Cash Flow (TWD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.37x | NT$173.60 Million | NT$473.77 Million | NT$300.16 Million | ▼ -31.4% |
| 2024 | 0.53x | NT$352.51 Million | NT$660.12 Million | NT$307.61 Million | ▲ +121.9% |
| 2023 | 0.24x | NT$109.41 Million | NT$454.54 Million | NT$345.13 Million | ▼ -58.2% |
| 2022 | 0.58x | NT$334.09 Million | NT$580.69 Million | NT$246.60 Million | ▲ +65.0% |
| 2021 | 0.35x | NT$209.26 Million | NT$600.08 Million | NT$390.81 Million | ▲ +65.6% |
| 2020 | 0.21x | NT$71.46 Million | NT$339.36 Million | NT$267.89 Million | ▲ +49.6% |
| 2019 | 0.14x | NT$46.56 Million | NT$330.81 Million | NT$284.25 Million | ▼ -58.2% |
| 2018 | 0.34x | NT$151.35 Million | NT$449.83 Million | NT$298.49 Million | ▼ -14.1% |
| 2017 | 0.39x | NT$238.18 Million | NT$607.87 Million | NT$369.68 Million | ▼ -41.1% |
| 2016 | 0.67x | NT$377.77 Million | NT$568.06 Million | NT$190.30 Million | ▼ -7.9% |
| 2015 | 0.72x | NT$277.36 Million | NT$383.93 Million | NT$106.57 Million | ▲ +20.6% |
| 2014 | 0.60x | NT$222.25 Million | NT$371.06 Million | NT$148.81 Million | ▲ +11.0% |
| 2013 | 0.54x | NT$109.68 Million | NT$203.21 Million | NT$93.53 Million | ▲ +85.0% |
| 2012 | 0.29x | NT$45.06 Million | NT$154.46 Million | NT$109.40 Million | ▼ -57.6% |
| 2011 | 0.69x | NT$169.24 Million | NT$246.09 Million | NT$76.85 Million | ▲ +18.4% |
| 2010 | 0.58x | NT$174.81 Million | NT$300.89 Million | NT$126.08 Million | ▼ -14.5% |
| 2009 | 0.68x | NT$243.36 Million | NT$358.02 Million | NT$114.67 Million | ▼ -53.4% |
| 2008 | 1.46x | NT$609.60 Million | NT$417.51 Million | NT$192.08 Million | ▲ +17.1% |
| 2007 | 1.25x | NT$402.19 Million | NT$322.49 Million | NT$79.70 Million | ▼ -5.6% |
| 2006 | 1.32x | NT$611.33 Million | NT$462.88 Million | NT$148.45 Million | ▲ +7.9% |
| 2005 | 1.22x | NT$705.10 Million | NT$575.91 Million | NT$129.19 Million | ▲ +14.6% |
| 2004 | 1.07x | NT$3.03 Billion | NT$2.84 Billion | NT$192.93 Million | ▲ +3.9% |
| 2003 | 1.03x | NT$3.51 Billion | NT$3.42 Billion | NT$94.39 Million | — |